| Name | Title | Contact Details |
|---|
Flokk is a prominent European manufacturer of workplace furniture, known for its commitment to sustainable and ergonomic design. Established in 2017, the company brings together nine heritage brands, each with a rich history, to promote user well-being and environmental responsibility. Flokk emphasizes innovation in seating solutions and has a strong presence across Europe, Asia, and the US. The company specializes in ergonomic office chairs, height-adjustable desks, meeting tables, and workspace accessories. Flokk prioritizes circular design principles, utilizing recycled materials and ensuring that its products are repairable and recyclable. With a focus on reducing carbon emissions through localized production, Flokk aims for climate-positive operations while supporting physical health through its furniture designs. Headquartered in Norway, Flokk operates production facilities in Switzerland, Poland, Norway, and the US, serving a diverse customer base that includes corporate offices, co-working spaces, and public sector organizations.
The Enoch Pratt Free Library is one of the oldest free public library systems in the United States. We serve the residents of Baltimore with branches throughout the city, and the residents of Maryland as the State Library Resource Center. Our mission is to provide equal access to information and services that empower, enrich, and enhance the quality of life for all. http://www.prattlibrary.org/jobs
Saddle Rock Legal Group partners with other leading law firms across the United States to provide legal representation for victims of mass torts. These partnerships allow us to offer our clients a wider range of resources and expertise and a greater ability to handle complex cases on a national level. Our partner firms are carefully selected based on their experience and reputation in the field of mass torts, and we work closely with them to provide the highest level of legal representation to our clients. If you have been affected by a mass tort and are seeking legal representation, Saddle Rock Legal Group and our network of partners may be able to help you seek justice and compensation.
Segerstrom Center for the Arts is a leading performing arts complex located in Costa Mesa, California. Established in 1986 and renamed in 2011, it spans 14 acres and is recognized as Orange County’s largest non-profit arts organization. The Center features multiple venues, including Segerstrom Hall, Renée and Henry Segerstrom Concert Hall, Samueli Theater, and Judy Morr Theater, hosting a wide range of performances. The Center offers live performances that include Broadway shows, classical concerts, dance, and contemporary acts. It also provides venue rentals for private events and seminars, along with arts-based education programs through the Lawrence and Kristina Dodge Education Center. With a mission focused on artistic excellence and community engagement, the Center has welcomed over 20 million visitors and premiered over 60 world-class productions since its inception.
IMUNON is a fully integrated, clinical stage biotechnology company focused on advancing a portfolio of innovative treatments that harness the bodys natural mechanisms to generate safe, effective, and durable responses across a broad array of human diseases. IMUNON has two platform technologies: Our TheraPlas® platform for the development of immunotherapies and other anti-cancer nucleic acid-based therapies and our PLACCINE platform for the development of nucleic acid vaccines for infectious diseases and cancer. The Companys lead clinical program, GEN-1, is a DNA-based immunotherapy for the localized treatment of advanced ovarian cancer currently in Phase II development. GEN-1 works by instructing the body to produce safe and durable levels of powerful cancer fighting molecules, such as interleukin-12 (IL-12) and interferon gamma (IFN-γ), at the tumor site. In addition, we are conducting pre-clinical proof-of-concept studies on a nucleic acid vaccine candidate targeting SARS-CoV-2 virus in order to validate our PLACCINE platform. IMUNONs platform technologies are based on the delivery of nucleic acids with novel synthetic delivery systems that are independent of viral vectors or devices. We will continue to leverage these platforms and to advance the technological frontier of plasmid DNA to better serve patients with difficult to treat conditions.